SPDR S&P Pharmaceuticals ETF $XPH Position Lowered by Compass Wealth Management LLC

Compass Wealth Management LLC cut its stake in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 57.8% during the third quarter, HoldingsChannel.com reports. The firm owned 11,255 shares of the company’s stock after selling 15,397 shares during the period. Compass Wealth Management LLC’s holdings in SPDR S&P Pharmaceuticals ETF were worth $732,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Bank of America Corp DE increased its stake in SPDR S&P Pharmaceuticals ETF by 128.0% in the 1st quarter. Bank of America Corp DE now owns 811,939 shares of the company’s stock valued at $43,918,000 after buying an additional 455,802 shares during the period. Parkway Wealth Management Group LLC purchased a new stake in SPDR S&P Pharmaceuticals ETF in the 3rd quarter worth approximately $24,754,000. First Citizens Bank & Trust Co. acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF during the 3rd quarter valued at $11,083,000. Private Advisor Group LLC acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF during the 1st quarter valued at $3,017,000. Finally, Integrated Wealth Concepts LLC acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF during the 2nd quarter valued at $3,350,000.

SPDR S&P Pharmaceuticals ETF Stock Up 0.5%

SPDR S&P Pharmaceuticals ETF stock opened at $64.28 on Friday. The company’s fifty day simple moving average is $67.55 and its 200-day simple moving average is $64.06. SPDR S&P Pharmaceuticals ETF has a 12 month low of $47.60 and a 12 month high of $74.35. The stock has a market cap of $453.17 million, a P/E ratio of 14.28 and a beta of 0.61.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.